Lusofarmaco has a long tradition in the cardiovascular field, thanks to many years of interest in cardiological drugs.
The company drug list belongs to several pharmacological classes such as calcium-channel blockers, nitrates, beta-blockers, statins, and a drug for the treatment of arterial hypotension, each represented by molecules of recognized efficacy and consolidated clinical use.

Brand name Molecule ATC category Packaging Class
Aloneb Nebivolol + HCTZ Beta-blockers + diuretic 28 tablets 5/12,5 mg A
28 tablets 5/25 mg A
Altiazem Diltiazem hydrochloride Calcium antagonists 50 tablets 60 mg A
24 tablets retard 120 mg A
14 capsules retard 300 mg A
Bifril Zofenopril ACE-inhibitors 28 tablets 30 mg  
12 tablets 7,5 mg A
Bifrizide Zofenopril + HCTZ ACE-inhibitors + Diuretics 28 tablets 30 mg / 12,5 mg A
Diuremid Torasemide Diuretic 14 scored tablets 10 mg A
10 mg / 2 ml solutions for injections - 5 vials A
200 mg / 20 ml solutions for injections - 1 vial


 Exorta  Rosuvastatine  HMG-CoA reductase inhibitors  28 tablets 5mg  A13
 Exorta  Rosuvastatine  HMG-CoA reductase inhibitors  28 tablets 10mg  A13
 Exorta  Rosuvastatine  HMG-CoA reductase inhibitors  28 tablets 20mg  A13
 Exorta  Rosuvastatine  HMG-CoA reductase inhibitors  28 tablets 40mg  A13
 Ezateros  Rosuvastatine + Ezetimibe  Lipid Regulators  28 film-coated tablets 5mg/10mg  A13
 Ezateros  Rosuvastatine + Ezetimibe  Lipid Regulators  28 film-coated tablets 10mg/10mg  A13
 Ezateros  Rosuvastatine + Ezetimibe  Lipid Regulators  28 film-coated tablets 20mg/10mg  A13
Gutron Midodrine Adrenergics and dopaminergics 30 tablets 2,5 mg C
drops 30 ml 0,25% C
6 vials 5 mg / 2 ml C
Monocinque Isosorbide-5-mononitrate Organic nitrates 50 tablets 20 mg A
30 tablets 40 mg A
Retard - 30 capsules 50 mg A
Retard - 30 capsules 80 mg A
Nobistar Nebivolol Beta-blocker 28 tablets 5 mg A
Prasterol Pravastatin sodium HMG-CoA reductase inhibitors 10 tablets 20 mg A13
14 tablets 40 mg A13
Tranex Tranexamic acid Antihaemorrhagics 30 capsules 250 mg A
30 capsules 500 mg A
6 vials 500 mg/5 ml A

Our products

Lusofarmaco can claim extensive know-how in various therapeutic areas: cardiovascular and respiratory diseases, antibiotic therapy, neuropsychiatry and gynecology.

Research & Development

For many years, Lusofarmaco has been mainly a national company, with a portfolio focused on well-established medicinal products, which have been the reference drugs in their respective therapeutic areas.


The science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine-related problem.

Registered Office:
Milanofiori – Strada 6, Edificio L – 20089 Rozzano (MI)
Tel. 02-516555.1 - Fax 02-516555.249

Registration No. In Registrar Of Companies: 00714810157
Registrar Of Companies' Office: Milano
Registered Capital: € 130.000 I.V.
Capital Reported In Last Financial Statement: € 130.000
Company subject to the direction and coordination of A. Menarini Industrie Farmaceutiche Riunite Srl


Copyright 2021 Istituto Lusofarmaco D'Italia S.p.A.